Literature DB >> 4024863

Glial fibrillary acidic protein in medulloblastomas.

T Kumanishi, K Washiyama, K Watabe, K Sekiguchi.   

Abstract

Two cases of medulloblastoma are described which show positive immunostaining for glial fibrillary acidic protein (GFAP) in many cells. The surgical and autopsy specimens were examined by the indirect immunoperoxidase method. Positive staining for GFAP was demonstrated in the small, round to polygonal cells in both surgical specimens and in the small spindle cells in the autopsy specimen of one case. In the small, round to polygonal cells positive GFAP was shown as a perinuclear brown rim or intracytoplasmic brown droplet. In the small spindle cells, the cytoplasm and the polar processes were stained. Except for GFAP staining, these positive cells were morphologically indistinguishable from the accompanying unstained cells, indicating that GFAP was expressed in the medulloblastoma cells. Considering that GFAP is specific for astrocytes, these findings suggest the potential of astrocytic differentiation in the neoplastic cells of these medulloblastomas. The findings obtained in other 28 medulloblastomas examined in parallel are also discussed briefly.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4024863     DOI: 10.1007/bf00688118

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Morphological studies of hamster brain cells transformed in vitro by a human papovavirus BK.

Authors:  R Tanaka; K Sekiguchi; K Ueki; D H Gilden; H Koprowski
Journal:  Acta Neuropathol       Date:  1978-03-15       Impact factor: 17.088

2.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

3.  SSPE: immunohistochemical demonstration of measles virus antigen(s) in paraffin sections.

Authors:  T Kumanishi; S In
Journal:  Acta Neuropathol       Date:  1979-11       Impact factor: 17.088

4.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

5.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence.

Authors:  A Bignami; L F Eng; D Dahl; C T Uyeda
Journal:  Brain Res       Date:  1972-08-25       Impact factor: 3.252

6.  Immunological study of the glial fibrillary acidic protein.

Authors:  C T Uyeda; L F Eng; A Bignami
Journal:  Brain Res       Date:  1972-02-11       Impact factor: 3.252

7.  Differentiation of Medulloblastoma. Studies including immunohistochemical localization of glial fibrillary acidic protein.

Authors:  J O Palmer; A G Kasselberg; M G Netsky
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

8.  Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children.

Authors:  E Schindler; F Gullotta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system.

Authors:  N A Tascos; J Parr; N K Gonatas
Journal:  Hum Pathol       Date:  1982-05       Impact factor: 3.466

10.  Glial fibrillary acidic protein in human gliomas.

Authors:  J D van der Meulen; H J Houthoff; E J Ebels
Journal:  Neuropathol Appl Neurobiol       Date:  1978 May-Jun       Impact factor: 8.090

View more
  9 in total

1.  Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.

Authors:  K Washiyama; Y Muragaki; L B Rorke; V M Lee; S C Feinstein; M J Radeke; D Blumberg; D R Kaplan; J Q Trojanowski
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system.

Authors:  G Reifenberger; J Szymas; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.

Authors:  R T Woodburn; B Azzarelli; J F Montebello; I E Goss
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

4.  Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors.

Authors:  F E Franke; W Schachenmayr; M Osborn; M Altmannsberger
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

5.  Medulloblastoma. An immunohistological study of 50 cases.

Authors:  F F Cruz-Sanchez; M L Rossi; J T Hughes; M M Esiri; H B Coakham
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Lipomatous differentiation in a medulloblastoma.

Authors:  L Chimelli; M D Hahn; H Budka
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Medulloblastoma: histological evaluation and prognosis. A clinical, immunohistochemical and electron microscopic study.

Authors:  J Szymas; W Biczysko; P Gabryel; S Morkowski
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

8.  Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.

Authors:  T Maraziotis; E Perentes; E Karamitopoulou; Y Nakagawa; E C Gessaga; A Probst; A Frankfurter
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?

Authors:  Alessandra Ciucci; Daniela Meco; Ilaria De Stefano; Daniele Travaglia; Gian Franco Zannoni; Giovanni Scambia; Riccardo Riccardi; Anna Saran; Mariateresa Mancuso; Daniela Gallo
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.